Found 9 matching trials
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) PHASE3 This study will examine the safety and efficacy of the addition of sitaglip...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019) PHASE3 The purpose of this study is to evaluate the efficacy and safety of omarigl...
Show More Location
Multiple Locations
Learn More & Join Trial
Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) PHASE3 The purpose of this study is to determine the safety and efficacy of an inv...
Show More Location
Multiple Locations
Learn More & Join Trial
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies PHASE2 This was a 10-week, placebo-controlled, randomized study to investigate the...
Show More Location
National Research Institute
Learn More & Join Trial
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) PHASE3 The purpose of this study is to determine the safety and tolerability of an...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics PHASE3 The purpose of this study is to evaluate the efficacy and safety of aloglip...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients PHASE2 The primary aim is to evaluate Efficacy, Safety and Tolerability of AZD1656...
Show More Learn More & Join Trial
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) PHASE3 The purpose of the study is to compare how sitagliptin and glipizide lower ...
Show More Location
Multiple Locations
Learn More & Join Trial
Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) PHASE3 A clinical study to determine the safety and efficacy of sitagliptin in pat...
Show More Location
Multiple Locations
Learn More & Join Trial